SAM
MNTA

Senzar Asset Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Senzar Asset Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-313,296
Closed -$4.18M – 33
2017
Q1 		$4.18M Sell
313,296
-218,602
-41% -$3.42M 1.06% 24
2016
Q4 		$8.01M Sell
531,898
-430,200
-45% -$5.68M 2.12% 15
2016
Q3 		$11.2M Buy
962,098
+153,900
+19% +$1.81M 2.91% 12
2016
Q2 		$8.73M Sell
808,198
-391,693
-33% -$4.04M 1.9% 17
2016
Q1 		$11.1M Buy
1,199,891
+657,800
+121% +$7.08M 2.2% 15
2015
Q4 		$8.04M Buy
+542,091
New +$9.07M 0.89% 26
2015
Q2 		– Sell
-695,016
Closed -$10.6M – 44
2015
Q1 		$10.6M Buy
695,016
+111,300
+19% +$1.45M 2.57% 15
2014
Q4 		$7.03M Buy
583,716
+129,116
+28% +$1.48M 2.06% 23
2014
Q3 		$5.16M Buy
454,600
+69,700
+18% +$795K 1.51% 19
2014
Q2 		$4.65M Buy
+384,900
New +$4.55M 1.78% 21

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Senzar Asset Management's MNTA Position: Q2 2017 in Review

Senzar Asset Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q2 2017, closing a stake of 313,296 shares — an estimated $4.18M sold.

Senzar Asset Management first reported a position in MNTA in Q2 2014 and held it in 10 quarters. The position peaked at $11.2M in Q3 2016. 164 funds tracked by Wall St. Rank hold MNTA as of Q2 2017.

  • Senzar Asset Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
  • Senzar Asset Management sold 313,296 Momenta Pharmaceuticals, Inc. shares in Q2 2017, an estimated $4.18M.
  • Senzar Asset Management first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2014 and held it in 10 quarters.
  • Senzar Asset Management's Momenta Pharmaceuticals, Inc. position peaked at $11.2M in Q3 2016.
  • 164 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q2 2017.

Based on Senzar Asset Management's 13F filing for Q2 2017, filed 11 Aug 2017.